Celloram Inc.

Nakamura is advising Celloram's cell therapy development program team. Currently, John is the Jane and Lee Seidman Chair in Pediatric Cancer Innovation, Chief of Pediatric Hematology-Oncology, and Director of the Angie Fowler Adolescent and Young Adult Cancer Institute at University Hospitals Rainbow Babies & Children’s Hospital. Kim is serving as the Vice-Chairman and CSO of Theragen Etex Co. Kim also served as the Director of the Precision Medicine Research Center in the Advanced Institutes of Convergence Technology at Seoul National University in South Korea, the Director for the Lee Gil Ya Cancer and Diabetes Institute in South Korea, and senior investigator at the Laboratory of Cell Regulation and Carcinogenesis of the National Cancer Institute. Pareek is a highly regarded research scientist and successful bioentrepreneur. Lim is an accomplished research scientist with expertise in molecular biology and cancer research. Lim’s innovative research efforts have been supported by numerous research awards, including support from the US Department of Defense, and are reported in numerous high-impact publications. Lim is advancing the development of next-generation technologies that form the foundation of the Celloram product pipeline.